Pharma Journalist 9038 posts 0 comments

AM-Pharma B.V., an emerging leader focused on the treatment of kidney disease, sepsis and organ injury, announced that the first patients with COVID-19 infection and sepsis-associated…
Read More...

SMi Reports: Innovations in technologies and applications of RNA-based medicine We have witnessed significant growth and innovation in the RNA market. The 2-day agenda for the…
Read More...

Xencor, Inc. a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies for the treatment of cancer and autoimmune diseases, and The University of Texas MD…
Read More...

A new COVID-19 drug screening and resistance hub will be established in Scotland, based at the MRC-University of Glasgow Centre for Virus Research (CVR). The ground-breaking project,…
Read More...

RedHill Biopharma Ltd. a specialty biopharmaceutical company, today announced that RHB-204 has been granted Fast Track designation by the U.S. Food and Drug Administration (FDA) for its…
Read More...

Dewpoint Therapeutics, the biomolecular condensates company, announced a new research collaboration with Pfizer for the development of potential therapeutics for the treatment of…
Read More...

Morphic Therapeutic a biopharmaceutical company developing a new generation of oral integrin therapies for the treatment of serious chronic diseases, announced the expansion of its…
Read More...

Akston Biosciences, which develops new classes of biologic therapeutics, and LakePharma, a leading U.S.-based CRDMO serving the biotechnology community, announced that they have…
Read More...

Angelini Pharma, an international pharmaceutical company which is a part of the private Italian Angelini Group – and Arvelle Therapeutics, a Swiss-based biopharmaceutical company…
Read More...

AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), is the first manufacturer of Orchard Therapeutics' Libmeldy, which was…
Read More...